Decision Making in Transmasculine Genital Reconstruction Surgery (TMGRS)

Information

  • Research Project
  • 10220958
  • ApplicationId
    10220958
  • Core Project Number
    R21DK124733
  • Full Project Number
    5R21DK124733-02
  • Serial Number
    124733
  • FOA Number
    PAR-18-743
  • Sub Project Id
  • Project Start Date
    7/15/2020 - 4 years ago
  • Project End Date
    4/30/2022 - 2 years ago
  • Program Officer Name
    BARTHOLD, JULIA SPENCER
  • Budget Start Date
    5/1/2021 - 3 years ago
  • Budget End Date
    4/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    4/20/2021 - 3 years ago

Decision Making in Transmasculine Genital Reconstruction Surgery (TMGRS)

PROJECT SUMMARY Transmasculine genital reconstruction surgeries (TMGRS), including phalloplasty and metoidioplasty, are increasingly performed and medically necessary for many to facilitate gender identity congruence, however, recent studies demonstrate that up to half of patients in the United States identifying as transgender male or gender non-binary have uncertainty or decisional conflict surrounding these procedures. These surgeries require multiple, complex, decisions by patients including surgical timing, whether to have removal of internal reproductive organs (vagina, uterus, and ovaries), whether to plan for future fertility, what type of genital reconstruction to have (metoidioplasty versus phalloplasty); all of which have lasting implications for future fertility, urinary and sexual function. Furthermore, TMGRS are associated with a high risk of costly urologic complications including up to 50% urethral stricture and fistula rate potentially requiring repeat procedures, prolonged catheterization, genitourinary infection, and lower urinary tract compromise. In these complex, preference-sensitive treatment decisions it is paramount to understand patients? decisional needs to empower them to make quality decisions that align with their personal values and goals. However, there is a lack of understanding of patients? decisional needs and factors contributing to decisional conflict surrounding TMGRS. Given the high rate of uncertainty, it follows that there is a lack of TMGRS decision support in the U.S. which may lead to poor quality decisions, further adding to existing transgender social, emotional, and health disparities. In this study, we propose to use triangulation mixed methods grounded in the Ottawa Decision Support Framework (ODSF) (1) to explore patients? decisional needs and factors potentially contributing to decisional conflict in TMGRS decision-making in both patients (who are future possible, scheduled for, or recently undergone TMGRS) and providers. We will utilize semi-structured interviews with patients and providers to explore ODSF constructs contributing to decisional conflict including lack of knowledge of procedural risk, benefits, and alternatives; lack of clarity with personal values and goals of care; poor health, and lack of support and stratify common themes by stage of decision-making and by patients and providers. Additionally, we will (2) develop a preliminary decision aid prototype drawing on content developed by literature review, expert reconstruction surgeon panel, multi-specialty transgender care providers, and patients to assist and empower patients in TMGRS decision-making. We will leverage experts in transgender genital reconstruction, qualitative mixed methods research, and decision aid creation to carry out this work. Successful completion of this study will contribute to a better understanding of TMGRS decisional needs and the development of a patient-centered decision aid prototype designed to increase knowledge, reduce decisional conflict, improve decisional quality, and inform a future prospective study evaluating the broad acceptability, feasibility, and efficacy of the TMGRS decision aid.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R21
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
    172621
  • Indirect Cost Amount
    21930
  • Total Cost
    194551
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:194551\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DARTMOUTH-HITCHCOCK CLINIC
  • Organization Department
  • Organization DUNS
    150883460
  • Organization City
    LEBANON
  • Organization State
    NH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    037561000
  • Organization District
    UNITED STATES